SpringWorks Therapeutics Stock (NASDAQ: SWTX) stock price, news, charts, stock research, profile.
You can purchase shares of SpringWorks Therapeutics (NASDAQ:SWTX) through any online brokerage.
Other companies in SpringWorks Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX), PTC Therapeutics (NASDAQ:PTCT) and Protagonist Therapeutics (NASDAQ:PTGX).
SpringWorks Therapeutics has a consensus price target of $61.71.
The stock price for SpringWorks Therapeutics (NASDAQ: SWTX) is $38.0332 last updated December 16, 2024 at 5:52 PM EST.
There are no upcoming dividends for SpringWorks Therapeutics.
SpringWorks Therapeutics’s Q4 earnings are confirmed for Tuesday, February 25, 2025.
There is no upcoming split for SpringWorks Therapeutics.
SpringWorks Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.